Zobrazeno 1 - 10
of 119
pro vyhledávání: '"Kazuyuki, Shirai"'
Publikováno v:
Clinical and Experimental Hypertension, Vol 42, Iss 6, Pp 545-552 (2020)
Background Renin is the starting point of the renin angiotensin (RA) system cycle. Aliskiren (AL), which is a direct renin inhibitor, suppressed the entire RA cycle. In the present study, the efficacy of add-on of AL treatment in patients with essent
Externí odkaz:
https://doaj.org/article/dd08cac8df8446c59f67aad6834f8d93
Publikováno v:
Clinical and Experimental Hypertension, Vol 42, Iss 5, Pp 438-448 (2020)
Background: This study investigated whether a combination drug containing an angiotensin II receptor blocker (ARB) and a calcium channel blocker (CCB) could provide effective antihypertensive therapy. Methods: A multicenter, prospective, open-label s
Externí odkaz:
https://doaj.org/article/0a25126994704a9b9dc743846f96d310
Autor:
Yosuke Takamiya, Keisuke Okamura, Kazuyuki Shirai, Tetsu Okuda, Kunihisa Kobayashi, Hidenori Urata
Publikováno v:
Clinical and Experimental Hypertension, Vol 42, Iss 3, Pp 197-204 (2020)
Objective: We purpose to confirm the effect of teneligliptin (Tenelia), a selective dipeptidyl peptidase-4 (DPP-4) inhibitor, on glycemic control and non-glucose risk factors for macroangiopathy, including blood pressure, lipid metabolism, and body w
Externí odkaz:
https://doaj.org/article/dc5d542dfb4c4a4689dc9a1a46eae9c1
Autor:
Motoyasu Miyazaki, Koichi Matsuo, Masanobu Uchiyama, Yoshihiko Nakamura, Yuya Sakamoto, Momoko Misaki, Kaoko Tokura, Shiro Jimi, Keisuke Okamura, Sen Adachi, Tomohiko Yamamoto, Kazuyuki Shirai, Hidenori Urata, Osamu Imakyure
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 6, Iss 1, Pp 1-11 (2020)
Abstract Background Inappropriate dosing of direct oral anticoagulants (DOACs) has been associated with clinical safety and efficacy; however, little is known about clinical data associated with an inappropriate DOAC dosing in Japan. In addition, the
Externí odkaz:
https://doaj.org/article/ceba16bf961246adabeb4c98dae885b4
Publikováno v:
Clinical and Experimental Hypertension, Vol 40, Iss 2, Pp 99-106 (2018)
Objective: When hypertension is uncontrolled by routine treatment with an angiotensin II receptor blocker (ARB) and the calcium channel blocker amlodipine (5 mg), the dose of amlodipine can be increased or a diuretic can be added. We investigated the
Externí odkaz:
https://doaj.org/article/5f48ef1cc4ba46e6bbab18e94458c070
Publikováno v:
Clinical and Experimental Hypertension, Vol 40, Iss 2, Pp 112-117 (2018)
The aim of the present study was to establish a convenient clinically applicable assay method for chymase-dependent angiotensin II forming activity of circulating mononuclear leukocytes (CML), which was potentially a marker of tissue chymase activity
Externí odkaz:
https://doaj.org/article/8bef7b3947f1478eaef0e8587c618f06
Autor:
Keisuke Okamura, Shunsuke Satou, Yusuke Kato, Yusuke Kogata, Masatoshi Matsushima, Kazuyuki Shirai, Hidenori Urata
Publikováno v:
Journal of Clinical Medicine Research
Background No methods exist for confirming nerve ablation in catheter-based renal sympathetic denervation (RDN). Methods We investigated the feasibility of using intravascular ultrasound (IVUS) to locate nerves and observe nerve integrity changes dur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb57c3cc000a75b370997b039f2a1955
http://europepmc.org/articles/PMC8734512
http://europepmc.org/articles/PMC8734512
Autor:
Tomohiko Yamamoto1 tomohiko0326@gmail.com, Kazuyuki Shirai1, Keisuke Okamura1, Hidenori Urata1
Publikováno v:
American Journal of Case Reports. 7/25/2019, Vol. 20, p1089-1093. 5p.
Autor:
Bo Zhang, Akira Matsunaga, David L. Rainwater, Shin-ichiro Miura, Keita Noda, Hiroaki Nishikawa, Yoshinari Uehara, Kazuyuki Shirai, Masahiro Ogawa, Keijiro Saku
Publikováno v:
Journal of Lipid Research, Vol 50, Iss 9, Pp 1832-1841 (2009)
Electronegative LDL, a charge-modified LDL (cm-LDL) subfraction that is more negatively charged than normal LDL, has been shown to be inflammatory. We previously showed that pravastatin and simvastatin reduced the electronegative LDL subfraction, fas
Externí odkaz:
https://doaj.org/article/591673eb5bd04c09a3707bab29862395
Publikováno v:
The American Journal of Case Reports
Patient: Female, 19 Final Diagnosis: Renovascular hypertension Symptoms: Hypertension Medication: Anti-hypertensive agents Clinical Procedure: Percutaneous transluminal renal angioplasty Specialty: Cardiology Objective: Unusual or unexpected effect o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fcfc2dc8c81b2760a6d47cdc678c121
https://doi.org/10.12659/ajcr.916105
https://doi.org/10.12659/ajcr.916105